These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 563892)

  • 1. Poliomyelitis surveillance in England and Wales, 1969-1975.
    Smith JW; Wherry PJ
    J Hyg (Lond); 1978 Feb; 80(1):155-67. PubMed ID: 563892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paralytic poliomyelitis in England and Wales, 1985-91.
    Joce R; Wood D; Brown D; Begg N
    BMJ; 1992 Jul; 305(6845):79-82. PubMed ID: 1322218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
    Strebel PM; Aubert-Combiescu A; Ion-Nedelcu N; Biberi-Moroeanu S; Combiescu M; Sutter RW; Kew OM; Pallansch MA; Patriarca PA; Cochi SL
    Am J Epidemiol; 1994 Dec; 140(12):1111-24. PubMed ID: 7998593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paralytic poliomyelitis in England & Wales, 1970-84.
    Begg NT; Chamberlain R; Roebuck M
    Epidemiol Infect; 1987 Aug; 99(1):97-106. PubMed ID: 3609178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paralytic poliomyelitis in England and Wales 1976-7.
    Collingham KE; Pollock TM; Roebuck MO
    Lancet; 1978 May; 1(8071):976-7. PubMed ID: 76901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
    Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
    N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies.
    Varughese PV; Carter AO; Acres SE; Furesz J
    Can J Public Health; 1989; 80(5):363-8. PubMed ID: 2804867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paralytic poliomyelitis epidemic of 1978 in Jordan: epidemiological implications.
    Khuri-Bulos N; Melnick JL; Hatch MH; Dawod ST
    Bull World Health Organ; 1984; 62(1):83-8. PubMed ID: 6609022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of paralytic poliomyelitis in the United States.
    Schonberger LB; Kaplan J; Kim-Farley R; Moore M; Eddins DL; Hatch M
    Rev Infect Dis; 1984; 6 Suppl 2():S424-6. PubMed ID: 6740085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.
    Hovi T; Cantell K; Huovilainen A; Kinnunen E; Kuronen T; Lapinleimu K; Pöyry T; Roivainen M; Salama N; Stenvik M
    Lancet; 1986 Jun; 1(8495):1427-32. PubMed ID: 2872526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of poliomyelitis in France: epidemiology and vaccine status.
    Malvy DJ; Drucker J
    Public Health Rev; 1993-1994; 21(1-2):41-9. PubMed ID: 8041889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.
    Prevots DR; Ciofi degli Atti ML; Sallabanda A; Diamante E; Aylward RB; Kakariqqi E; Fiore L; Ylli A; van der Avoort H; Sutter RW; Tozzi AE; Panei P; Schinaia N; Genovese D; Oblapenko G; Greco D; Wassilak SG
    Clin Infect Dis; 1998 Feb; 26(2):419-25. PubMed ID: 9502465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliomyelitis survey in Middle-East countries.
    Brigaud M; Aymard M; Thouvenot D; Chomel JJ; Mahmood RA; Mathew PP; Jafar AK
    Dev Biol Stand; 1978; 41():149-58. PubMed ID: 223907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
    Esteves K
    Bull World Health Organ; 1988; 66(6):739-46. PubMed ID: 3266113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.
    Nkowane BM; Wassilak SG; Orenstein WA; Bart KJ; Schonberger LB; Hinman AR; Kew OM
    JAMA; 1987 Mar; 257(10):1335-40. PubMed ID: 3029445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK; Strebel PM; de Quadros CA; Olivé JM
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014.
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Korotkova EA; Kozlovskaya LI; Baykova OY; Krasota AY; Gmyl AP
    Int J Infect Dis; 2018 Nov; 76():64-69. PubMed ID: 30201507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.